title: Cationic host defence peptides: potential as antiviral therapeutics.
abstract: There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led to the emergence of possible peptide therapies, with 15 currently in clinical trials. Advancements in understanding the antiviral potential of naturally occurring host defence peptides highlights the potential of a whole new class of molecules to be considered as antiviral therapeutics. Cationic host defence peptides, such as defensins and cathelicidins, are important components of innate immunity with antimicrobial and immunomodulatory capabilities. In recent years they have also been shown to be natural, broad-spectrum antivirals against both enveloped and non-enveloped viruses, including HIV-1, influenza virus, respiratory syncytial virus and herpes simplex virus. Here we review the antiviral properties of several families of these host peptides and their potential to inform the design of novel therapeutics.
authors: MRC Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, Scotland, UK.
authors: Emily
authors: E
authors: Gwyer Findlay
authors: Silke M
authors: SM
authors: Currie
authors: Donald J
authors: DJ
authors: Davidson
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000276:immunology* / Q000494:pharmacology*; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D010455:Peptides / Q000276:immunology* / Q000494:pharmacology*; D014777:Virus Diseases / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000998:Antiviral Agents; D010455:Peptides
references: J Virol. 2004 May;78(10):5147-56
references: 15113897
references: J Immunol. 2004 Jul 1;173(1):515-20
references: 15210812
references: Am J Respir Cell Mol Biol. 2010 Dec;43(6):692-702
references: 20097832
references: Lancet. 2012 Jun 9;379(9832):2151-61
references: 22579125
references: Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5118-24
references: 17962464
references: J Leukoc Biol. 2000 Jul;68(1):9-14
references: 10914484
references: J Allergy Clin Immunol. 2007 Apr;119(4):1022-5
references: 17353034
references: Nature. 2007 Oct 4;449(7162):564-9
references: 17873860
references: Immunology. 2002 Aug;106(4):517-25
references: 12153515
references: Annu Rev Immunol. 2004;22:181-215
references: 15032578
references: Regul Pept. 2001 Sep 15;101(1-3):157-61
references: 11495691
references: J Oral Pathol Med. 2013 Jan;42(1):53-60
references: 22680235
references: Hum Gene Ther. 1999 Apr 10;10(6):957-64
references: 10223729
references: PLoS One. 2012;7(2):e31996
references: 22389677
references: J Immunol. 2009 Aug 1;183(3):2122-32
references: 19596979
references: AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65
references: 15588337
references: J Immunol. 2006 Jul 15;177(2):782-6
references: 16818731
references: Science. 2002 Nov 1;298(5595):995-1000
references: 12351674
references: J Virol. 2005 Nov;79(22):14318-29
references: 16254366
references: J Immunol. 2006 Jun 1;176(11):6962-72
references: 16709857
references: AIDS. 2009 Jan 28;23(3):309-17
references: 19114868
references: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14961-6
references: 9843998
references: J Virol. 2010 Apr;84(8):4041-9
references: 20130047
references: Curr Protein Pept Sci. 2005 Feb;6(1):35-51
references: 15638767
references: Science. 2012 Jul 27;337(6093):477-81
references: 22722251
references: Am J Respir Cell Mol Biol. 1998 Sep;19(3):352-6
references: 9730862
references: J Immunol. 2003 Sep 15;171(6):3262-9
references: 12960356
references: PLoS Pathog. 2010 Jun 24;6(6):e1000959
references: 20585634
references: J Virol. 2009 Nov;83(21):11385-90
references: 19710146
references: J Infect Dis. 2007 Sep 15;196(6):835-43
references: 17703413
references: PLoS One. 2011;6(10):e26632
references: 22039520
references: J Biol Chem. 1992 Nov 15;267(32):23216-25
references: 1429669
references: FEBS Lett. 2005 Jan 3;579(1):162-6
references: 15620707
references: FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):59-64
references: 12900056
references: J Immunol. 2002 Oct 1;169(7):3883-91
references: 12244186
references: Infect Immun. 2004 Oct;72(10):5750-8
references: 15385474
references: J Immunol. 2012 Mar 15;188(6):2759-68
references: 22345650
references: J Immunol. 2006 Dec 15;177(12):8658-66
references: 17142766
references: J Immunol. 2006 Aug 1;177(3):1864-71
references: 16849498
references: FASEB J. 1996 Sep;10(11):1280-9
references: 8836041
references: FASEB J. 2007 Sep;21(11):2765-75
references: 17470569
references: Immunity. 2006 Mar;24(3):341-8
references: 16546102
references: FEMS Immunol Med Microbiol. 2009 Aug;56(3):233-40
references: 19527294
references: Antimicrob Agents Chemother. 2005 Jan;49(1):269-75
references: 15616305
references: AIDS. 2004 May 21;18(8):1217-8
references: 15166542
references: J Infect Dis. 2012 Oct 1;206(7):1012-9
references: 22837491
references: J Leukoc Biol. 2012 Oct;92(4):735-42
references: 22701042
references: J Allergy Clin Immunol. 2008 Aug;122(2):261-6
references: 18439663
references: J Immunol. 2009 Jul 1;183(1):480-90
references: 19542459
references: J Biol Chem. 2012 Aug 3;287(32):27014-9
references: 22700960
references: PLoS One. 2013 Aug 30;8(8):e73659
references: 24023689
references: Retrovirology. 2011 Jun 14;8:45
references: 21672195
references: Mol Divers. 2006 Nov;10(4):575-84
references: 16969721
references: J Innate Immun. 2009;1(5):413-20
references: 20375599
references: Infect Immun. 2000 Jul;68(7):4297-302
references: 10858248
references: J Allergy Clin Immunol. 2012 Oct;130(4):1007-8.e1
references: 22944482
references: J Biol Chem. 2006 Jan 27;281(4):2005-11
references: 16319062
references: J Biol Chem. 1996 Feb 23;271(8):4038-45
references: 8626737
references: Antimicrob Agents Chemother. 2005 Nov;49(11):4561-6
references: 16251296
references: Nature. 2011 Jan 20;469(7330):419-23
references: 21248850
references: J Biol Chem. 1997 Jun 13;272(24):15258-63
references: 9182550
references: Science. 2004 Jan 23;303(5657):467
references: 14739439
references: J Leukoc Biol. 2004 Jan;75(1):39-48
references: 12960280
references: Arch Virol. 2010 Apr;155(4):491-8
references: 20195655
references: J Clin Invest. 1985 Oct;76(4):1427-35
references: 2997278
references: Eur Respir J. 1998 Jan;11(1):104-11
references: 9543278
references: Cell Host Microbe. 2008 Jan 17;3(1):11-9
references: 18191790
references: J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):455-61
references: 22592582
references: Science. 1999 Oct 15;286(5439):525-8
references: 10521347
references: J Invest Dermatol. 2001 Jul;117(1):91-7
references: 11442754
references: J Innate Immun. 2012;4(4):361-70
references: 22739631
references: AIDS Res Hum Retroviruses. 2003 Oct;19(10):875-81
references: 14585219
references: J Clin Invest. 2005 Mar;115(3):765-73
references: 15719067
references: J Biol Chem. 2012 Aug 17;287(34):28821-38
references: 22733823
references: Peptides. 2010 Nov;31(11):1966-72
references: 20705109
references: J Biol Chem. 2006 Jul 7;281(27):18787-92
references: 16648135
references: J Immunol. 2004 Jan 15;172(2):1146-56
references: 14707090
references: Nat Immunol. 2005 Oct;6(10):995-1001
references: 16155572
references: Science. 1999 Oct 15;286(5439):498-502
references: 10521339
references: J Gen Virol. 2013 Jan;94(Pt 1):40-49
references: 23052388
references: J Immunol. 1991 Dec 15;147(12):4307-12
references: 1753101
references: J Immunol. 2012 Jul 1;189(1):304-11
references: 22634613
references: PLoS One. 2010 Nov 29;5(11):e15111
references: 21124745
references: J Immunol. 2004 Sep 1;173(5):2909-12
references: 15322146
references: J Exp Med. 2000 Oct 2;192(7):1069-74
references: 11015447
references: AIDS. 2003 Nov 7;17(16):F39-48
references: 14571200
references: Peptides. 2011 Jun;32(6):1117-22
references: 21539873
references: Nat Immunol. 2005 Jun;6(6):551-7
references: 15908936
references: J Leukoc Biol. 2009 Nov;86(5):1145-51
references: 19638499
references: J Exp Med. 2009 Aug 31;206(9):1983-94
references: 19703986
references: Curr Top Microbiol Immunol. 2006;306:27-66
references: 16909917
references: J Immunol. 2009 Jun 15;182(12):7878-87
references: 19494312
references: Curr HIV Res. 2007 Jul;5(4):410-5
references: 17627504
references: Crit Rev Immunol. 2008;28(3):185-200
references: 19024344
references: J Clin Invest. 2003 Jun;111(11):1665-72
references: 12782669
references: J Virol. 2003 Jan;77(1):460-9
references: 12477851
references: J Immunol. 2004 Apr 1;172(7):4637-45
references: 15034083
references: J Immunol. 2008 May 1;180(9):6176-85
references: 18424739
references: Blood. 1997 Oct 1;90(7):2796-803
references: 9326247
references: J Immunol. 2007 Jun 15;178(12):8046-52
references: 17548642
references: Nat Rev Microbiol. 2005 Mar;3(3):238-50
references: 15703760
references: Blood. 2007 Apr 1;109(7):2928-35
references: 17132727
references: J Innate Immun. 2012;4(4):337-48
references: 22441423
references: Blood. 2001 Jun 15;97(12):3951-9
references: 11389039
references: J Clin Invest. 1989 Dec;84(6):2017-20
references: 2592571
references: J Immunol. 2006 Jun 1;176(11):6900-5
references: 16709850
references: J Biol Chem. 2008 Aug 15;283(33):22417-29
references: 18567888
references: Infect Immun. 2002 Jun;70(6):3053-60
references: 12010997
references: J Virol. 1986 Dec;60(3):1068-74
references: 3023659
references: Antivir Chem Chemother. 2012 Aug 21;22(6):255-62
references: 22345365
references: AIDS. 1993 Aug;7(8):1129
references: 8397954
references: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1516-21
references: 16432216
references: Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1813-8
references: 11854483
references: J Biol Chem. 2008 Nov 7;283(45):31125-32
references: 18782756
references: Immunol Rev. 2012 Jan;245(1):84-112
references: 22168415
references: FEBS Lett. 1996 Nov 4;396(2-3):319-22
references: 8915011
references: Virology. 2008 Oct 10;380(1):136-43
references: 18752820
references: J Biol Chem. 2012 Jul 13;287(29):24554-62
references: 22637473
references: Clin Microbiol Rev. 2001 Oct;14(4):753-77, table of contents
references: 11585784
references: Biotechnol Lett. 2010 Mar;32(3):387-92
references: 19941035
references: Curr HIV Res. 2008 Nov;6(6):531-8
references: 18991618
references: J Immunol. 2011 Dec 1;187(11):5653-9
references: 22048772
references: J Leukoc Biol. 2011 Aug;90(2):343-56
references: 21551252
references: Nature. 2002 Jan 24;415(6870):389-95
references: 11807545
references: Nature. 2001 Nov 22;414(6862):454-7
references: 11719807
references: Infect Immun. 2011 Jan;79(1):459-73
references: 21041494
references: Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3657-65
references: 16186347
references: Cell. 1982 Dec;31(2 Pt 1):417-27
references: 6186384
references: Infect Immun. 1992 Aug;60(8):3446-7
references: 1639513
references: Int J Cancer. 2005 May 1;114(5):713-9
references: 15609314
references: J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):138-42
references: 15905728
references: J Immunol. 2006 Feb 15;176(4):2455-64
references: 16456005
references: Nucleic Acids Res. 2012 Jul;40(Web Server issue):W199-204
references: 22638580
references: Infect Immun. 2002 Jun;70(6):3068-72
references: 12010999
references: Open Microbiol J. 2008;2:49-59
references: 19088911
references: Nat Immunol. 2010 Jan;11(1):76-83
references: 19855381
references: Nat Rev Immunol. 2003 Sep;3(9):710-20
references: 12949495
references: Peptides. 2003 Nov;24(11):1647-54
references: 15019196
references: PLoS One. 2011;6(10):e25333
references: 22031815
references: J Leukoc Biol. 2009 Oct;86(4):891-902
references: 19581375
references: Antimicrob Agents Chemother. 2008 Mar;52(3):944-53
references: 18160518
references: Am J Pathol. 1998 May;152(5):1247-58
references: 9588893
references: J Immunol. 2008 Nov 15;181(10):7090-9
references: 18981129
references: J Gene Med. 2009 Mar;11(3):220-8
references: 19115333
references: J Immunol. 2004 Feb 1;172(3):1763-7
references: 14734759
references: J Immunol. 2005 Apr 15;174(8):4901-7
references: 15814717